Drug Discovery News
-
FDA affirms superiority of Pradaxa over warfarin
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 07 Jun, 2012
Singapore: US Food and Drug Administration has affirmed Boehringer Ingelheim's Pradaxa 150mg superior in reducing ischem...Read more
-
Sanofi withdraws diabetes drug NDA in the US
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 13 Sep, 2013
Singapore: Global pharmaceutical company, Sanofi has temporarily withdrawn new drug application (NDA) for lixisenatide i...Read more
-
Amgen to acquire Onyx for $10 bn cash
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 26 Aug, 2013
Singapore: Global biopharmaceutical company Amgen plans to acquire all the outstanding shares of Onyx Pharmaceuticals fo...Read more
-
Effient trial by Daiichi, Lilly fails to meet primary endpoint
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 27 Aug, 2012
Singapore: The TRILOGY ACS study, a phase III trial comparing prasugrel plus aspirin to clopidogrel plus aspirin in pati...Read more
-
Astellas Pharma opens office in Singapore
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 12 Dec, 2013
Singapore: Astellas Pharma, Japan's pharmaceutical giant with net sales of $10.7 billion and net income of $881 million ...Read more
-
A*STAR, GSK develop medicines for emerging markets
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 09 Apr, 2013
Singapore: GlaxoSmithKline (GSK) and A*STAR's Institute of Chemical and Engineering Sciences (ICES) have signed a five-y...Read more
-
Aussie firm gets TGA approval for pancreatic cancer drug
Drug Discovery | Regulatory | By BioSpectrum Bureau | 0 Comment | 18 Mar, 2014
Singapore: Australian biopharmaceutical company, Specialised Therapeutics Australia (STA), has recieved Therapeutic Good...Read more
-
Pharmaxis gets grants for fibrotic research
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 08 Jul, 2013
Singapore: Australian pharmaceutical company Pharmaxis' research projects conducted in conjunction with the University o...Read more
-
Regenerative Therapy for heart failure enters Ph III Trial
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: Belgian biotechnology company Cardio3 BioSciences (C3BS) has received authorization from the Belgian Federal ...Read more
-
Mesoblast to set up stem cell drug plant in Singapore
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 29 May, 2014
Singapore: Australian regenerative drug company, Mesoblast, is planning to expand its global manufacturing base and the ...Read more
-
Sanford-Burnham, Daiichi form new alliance
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 26 May, 2014
Singapore: US based Sanford-Burnham Medical Research Institute and Japan's Daiichi Sankyo have formed a three year disco...Read more
-
Boehringer, Eli Lilly to evaluate Trajenta for type 2 diabetes
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 21 Mar, 2013
Singapore: Boehringer Ingelheim and Eli Lilly have initiated phase IIIb trial to evaluate the glycaemic efficacy and saf...Read more
-
Taiwan firm NCE to get priority review in China
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 21 Mar, 2013
Singapore: Taiwan Liposome Company's multi-mechanistic anti-cancer new chemical entity Lipotecan has been accepted into ...Read more
-
Astrazeneca, China university in research deal
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 19 Dec, 2012
Singapore: AstraZeneca has signed a research collaboration with Fudan University, one of China's leading academic instit...Read more
-
Phylogica extends collaboration with Janssen Biotech
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 31 Jan, 2013
Singapore: Phylogica, a leading Australian peptide drug discovery company, has extended its collaboration with Janssen B...Read more
-
AstraZeneca, BMS gets positive regulatory feedback on Type 2 diabetes drug
Drug Discovery | Regulatory | By BioSpectrum Bureau | 0 Comment | 29 Nov, 2013
Singapore: Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has provided Ast...Read more
-
Regeneron acquires Sanofi eye care antibodies
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 06 May, 2013
Singapore: US-based Regeneron Pharmaceuticals has acquired exclusive rights to two families of novel antibodies from San...Read more
-
Teva, Xenon enter $335 mn deal for pain drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 12 Dec, 2012
Singapore: Israel-based Teva Pharmaceutical and Canada-based Xenon Pharmaceuticals have entered into a collaborative dev...Read more
